Quality Manager for HSCT | University College London Hospitals NHS Foundation Trust

A talented and motivated Quality Manager is sought to work within the stem cell transplant clinical and collection services to maintain the quality management system in line with JACIE, HTA and other regulatory bodies as required, and to facilitate inspections by them. The post holder should have excellent IT skills, be well organized and methodical with good communication skills. On the job training for Quality Management software will be provided where required. The post holder will work in direct support of the Lead Cancer Quality Manager and other members of the Cancer Quality Team. The role will also include working with the wider cancer management team to ensure that the service objectives are achieved in a timely fashion in line with key Trust priorities and prevailing best practice or accreditation, licensing or regulatory requirements. The postholder will be responsible for ensuring the effective operation and continual development of the Quality Management System, in collaboration with the Cancer Quality Team and HSCT multi-disciplinary team. The postholder will ensure compliance with new healthcare regulations, standards, and policies (e.g. JACIE/(rb) HTA). Support the development of PPGs as well as developing and maintaining governance frameworks that clarify roles, responsibilities, and decision‑making processes. Oversee all HSCT related incidents and facilitate a multi-disciplinary review of reported incidents, errors and near misses. Ensuring incidents are investigated in a timely fashion, and that they are tracked and trended to identify areas for improvement. Ensure learning is shared across the service to improve patient safety, clinical quality, and service delivery. The postholder also supports the identification of training needs, in relation to any audit recommendations, incident reports or development of new policies, procedures and guidelines. The postholder will also be required to line manage the Assistant Quality Manager for Cellular Therapies. Lead on internal and external audits, inspections, and quality reviews to ensure continuous improvement. University College London Hospitals NHS Foundation Trust (UCLH) is one of the most complex NHS trusts in the UK, serving a large and diverse population. We provide academically led acute and specialist services, to people from the local area, from throughout the United Kingdom and overseas. Our vision is to deliver top-quality patient care, excellent education, and world‑class research. We provide first‑class acute and specialist services across eight sites: University College Hospital (incorporating the Elizabeth Garrett Anderson Wing) National Hospital for Neurology and Neurosurgery Royal National ENT and Eastman Dental Hospitals University College Hospital Grafton Way Building Royal London Hospital for Integrated Medicine University College Hospital Macmillan Cancer Centre The Hospital for Tropical Diseases University College Hospital at Westmoreland Street We are dedicated to the diagnosis and treatment of many complex illnesses. UCLH specialises in women’s health and the treatment of cancer, infection, neurological, gastrointestinal and oral disease. It has world class support services including critical care, imaging, nuclear medicine and pathology. For the full Person Specification and more information regarding the main responsibilities of this role, please refer to the attached Job Description. Come and be a part of the best NHS trust in England to work for, according to our staff*. *UCLH top trust to work at in England- In the most recent NHS staff survey UCLH had the highest percentage of staff who said they would recommend us as a place to work, out of all general acute or acute/community NHS trusts in England – for the third year in a row. UCLH recognises the benefits of flexible working for staff – To find out more, visit: Flexible working. To discover more about what makes UCLH a great place to work, visit: Why Choose UCLH? This advert closes on Thursday 27 Nov 2025. #J-18808-Ljbffr